[ALNY] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
09-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -10.37%
YoY- -31.39%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 103,962 44,714 29,907 15,932 8,709 8,685 7,295 55.64%
PBT -177,903 -218,521 -163,481 -118,420 -90,129 -71,352 -44,389 26.00%
Tax 1,326 960 79 -2,577 -2,092 431 -315 -
NP -179,229 -219,481 -163,560 -118,420 -90,129 -71,783 -44,074 26.31%
Tax Rate - - - - - - - -
Total Cost 283,191 264,195 193,467 134,352 98,838 80,468 51,369 32.87%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin -172.40 -490.86 -546.90 -743.28 -1,034.89 -826.52 -604.17 -18.84%
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS -1.56 -2.02 -1.63 -1.34 -1.05 -0.85 -0.58 17.91%
EPS Diluted -1.56 -2.02 -1.63 -1.34 -1.05 -0.85 -0.58 17.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.